Dr Oliver Eden
Senior Business Unit Director

About

Oliver Eden, PhD, is a Senior Business Unit Director at Jabil for its Pharmaceutical Solutions division. Dr Eden brings experience from previous roles at Nypro (now Jabil) and Catalent Pharma Solutions. He holds a PhD in Biomaterials Engineering and Master’s in Mechanical Engineering from the University of Exeter (UK).
Dr Eden possesses a robust skill set that includes pharmaceuticals, forecasting, new business development, product development, biotechnology and more.

Contributions

EXPERT VIEW

DEVELOPMENTAL ADVANTAGES IN INJECTABLE COMBINATION DRUG PRODUCTS

Oliver Eden and Travis Webb consider how regulatory considerations and patient-centric device designs are transforming the landscape of self-administered injectable drugs.

More contributions

INTERVIEW

Connected Drug Delivery – Is the Near-Term Opportunity in Clinical Development? – an Interview with Oliver Eden

Oliver Eden of Jabil Healthcare looks at the factors influencing the return on investment metrics in clinical development and introduces Jabil’s autoinjector platform Qfinity™ and its connected version, Qfinity+™.

CONNECTIVITY

CONNECTED DRUG DELIVERY – MAXIMISING ACCESS BY DESIGN

Oliver Eden discusses the factors that drive the design and development of a reusable autoinjector solution. Foremost amongst these considerations is the patient, in terms of ease of use with the device itself and maximising access to the broadest possible population with a versatile, portfolio-enabling platform ready for the connected world.